UroGen Pharma Ltd.
URGN NASDAQ







Weekly Summary
UroGen Pharma Ltd. closed at 17.9500 (-4.98% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this — Price slope is downward, indicating persistent supply pressure. Volume and price are moving in the same direction — a constructive confirmation. Distance to baseline is narrowing — reverting closer to its fair-value track. Fresh short-term downside crossover weakens near-term tone.
Down-slope argues for patience; rallies can fade sooner unless participation improves.
Gauge maps the trend signal to a 0–100 scale.
How to read this — Range-bound conditions; conviction is limited until a break or acceleration emerges.
Wait for a directional break or improving acceleration.

Relative strength is Positive
(> 0%, outperforming).
Latest MRS: 17.65% (week ending Fri, 19 Sep 2025).
Slope: Falling over 8w.
Notes:
- Holding above the zero line indicates relative bid.
- MRS slope falling over ~8 weeks.
Conclusion
Positive setup. ★★★★⯪ confidence. Trend: Range / Neutral · -7.47% over window · vol 3.14% · liquidity convergence · posture mixed · RS outperforming
- Momentum is bullish and rising
- Liquidity confirms the price trend
- Mansfield RS: outperforming & rising
- Price is not above key averages
- Negative multi-week performance
Why: Price window -7.47% over w. Close is -8.93% below the prior-window high. Volume trend falling. Liquidity convergence with price. Trend state range / neutral. 4–8w crossover bearish. Momentum bullish and rising.
Tip: Most metrics include a hover tooltip where they appear in the report.